Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Feeling sluggish, tired, or cant focus
If the calculation is correct, consider splitting the dose
Int Immunopharmacol
diff ) infection, which is commonly seen in patients on long-term antibiotic therapy
Molecular Composition and Characteristics Component 1: BPC-157 (synthetic pentadecapeptide) Component 2: TB-500 (thymosin beta-4 analogue) Structure: Linear peptide chains supplied as a blended formulation Stability: High when stored under recommended laboratory conditions Molecular Stability and Storage Profile Supplied as a lyophilised powder for enhanced long-term stability Recommended storage: 20C for extended research use Sensitive to moisture, oxygen, and prolonged light exposure Predictable degradation at elevated temperatures Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Considerations Bacteriostatic water Sterile saline solutions Acidic laboratory buffers Compatible analytical-grade organic solvents Technical Specifications product Name BPC-157 + TB-500 Blend 10mg cas 137525-51-0, 77591-33-4 purity 99% (HPLC verified) unit Size 10 mg blended vial form Lyophilised peptide blend synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear synthetic peptide chains stability High under appropriate laboratory storage Analytical Validation and Quality Assurance HPLC purity verification for each peptide component Mass Spectrometry confirmation of molecular identity UV spectrophotometric concentration analysis Batch consistency and reproducibility testing Endotoxin and microbial screening for regulated research environments Regulatory and Research Compliance BPC-157 + TB-500 Blend 10mg is supplied strictly for laboratory research and in-vitro scientific investigation
Because the two peptides hit two separate receptors that both feed the same GH pulse, they are described in research as synergistic rather than additive: GHRH-driven and secretagogue-driven signals combine at the pituitary
US$ 24.42
US$ 22.14
US$ 28.16
